insights_auto
Waarom is SOBI gestegen 2,28%?
Meer informatiechevron_right
SOBI:STO
Swedish Orphan Biovitrum
SEKÂ 493,60
arrow_upward
+2,28%(+11,00) 1D
5 nov, 17:29:44 GMT+1 · SEK
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor SOBI genereren…
Openen
SEKÂ 486,00
Hoog
SEKÂ 496,00
Laag
SEKÂ 484,20
Beursw.
176,53Â mld.
Gem. vol.
337,83K
Volume
378,84K
Koers/winst-verhouding
26,22
52 wk hoog
SEKÂ 496,00
52 wk laag
SEKÂ 314,40
WPA
SEKÂ 18,83
Uitstaande aandelen
357,64Â mln.
Aantal medewerkers
2K
Openen
SEKÂ 486,00
Hoog
SEKÂ 496,00
Laag
SEKÂ 484,20
Beursw.
176,53Â mld.
Gem. vol.
337,83K
Volume
378,84K
Koers/winst-verhouding
26,22
52 wk hoog
SEKÂ 496,00
52 wk laag
SEKÂ 314,40
WPA
SEKÂ 18,83
Uitstaande aandelen
357,64Â mln.
Aantal medewerkers
2K
Nieuwsartikelen
Van webbronnen en nieuwspartners
TradingView
·
2 dagen geleden
Swedish Orphan Biovitrum Executive Sells, Buys Shares
Profiel
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Over Swedish Orphan Biovitrum